The combination of intermediate doses of thalidomide and dexamethasone reduces bone marrow micro-vessel density but not serum levels of angiogenic cytokines in patients with refractory/relapsed multiple myeloma
E. Hatjiharissi, E. Terpos, M. Papaioannou, C. Hatjileontis, V. Kaloutsi, G. Galaktidou, G. Gerotziafas, J. Christakis, K. ZervasVolume:
22
Year:
2004
Language:
english
Pages:
10
DOI:
10.1002/hon.738
File:
PDF, 288 KB
english, 2004